Juli Busquets
Overview
Explore the profile of Juli Busquets including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorribas M, Carnaval T, Secanella L, Pelaez N, Salord S, Gornals J, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685678
Surgical resection for ampullary lesions lacks clear guidelines. Pancreaticoduodenectomy (PD) is the standard treatment for malignant ampullary tumors but is often excessive for ampullary adenomas (AAs) due to its high...
2.
Velasquez-Rodriguez J, Loras C, Maisterra S, Colan-Hernandez J, Busquets J, Gornals J
Ther Adv Gastrointest Endosc
. 2024 Nov;
17:26317745241287319.
PMID: 39483523
Background: Endoscopic management of abdominal collections includes endoscopic ultrasound (EUS)-guided transmural drainage, transpapillar via endoscopic retrograde cholangiopancreatography (ERCP), and EUS-guided simple puncture-aspiration (SPA). The latter is little reported, and there...
3.
Gornals J, Sumalla-Garcia A, Quintana S, Luna-Rodriguez D, Velasquez-Rodriguez J, Puigcerver-Mas M, et al.
Ann Med
. 2024 Oct;
56(1):2416607.
PMID: 39428568
Background: Endoscopic ultrasound (EUS)-guided biliary rendezvous (RV) is an EUS-assisted technique described as a rescue method in cases of failed biliary cannulation endoscopic retrograde cholangiography (ERC). Current literature remains unclear...
4.
Busquets J, Secanella L, Carnaval T, Sorribas M, Serrano-Navidad M, Alba E, et al.
Cir Esp (Engl Ed)
. 2024 Sep;
102(12):633-641.
PMID: 39304131
Introduction: Embolization could increase the resectability of pancreatic tumors by supercharging visceral arterial perfusion prior to pancreatic surgery with arterial en-bloc resection. Its indications, however, are controversial. Methods: We retrospectively...
5.
Gornals J, Sumalla-Garcia A, Luna-Rodriguez D, Puigcerver-Mas M, Velasquez-Rodriguez J, Salord S, et al.
Gastroenterol Hepatol
. 2024 Jun;
48(2):502221.
PMID: 38906323
Background And Aims: Endoscopic ultrasound-guided pancreatic duct intervention (EUS-PDI) is one of the most technically challenging procedures. There remains a knowledge gap due to its rarity. The aim is to...
6.
Perez M, Hansen C, Burdio F, Sanchez-Velazquez P, Giuliani A, Lancellotti F, et al.
Eur J Surg Oncol
. 2024 May;
50(7):108375.
PMID: 38795677
Introduction: Distal Cholangiocarcinoma (dCCA) represents a challenge in hepatobiliary oncology, that requires nuanced post-resection prognostic modeling. Conventional staging criteria may oversimplify dCCA complexities, prompting the exploration of novel prognostic factors...
7.
Gornals J, Velasquez-Rodriguez J, Bas-Cutrina F, Garcia Garcia de Paredes A, Esteban J, Teran A, et al.
Surg Endosc
. 2024 Mar;
38(4):2148-2159.
PMID: 38448625
Background: Lumen-apposing metal stents (LAMS) have displaced double-pigtail plastic stents (DPS) as the standard treatment for walled-off necrosis (WON),β but evidence for exclusively using LAMS is limited. We aimed to...
8.
Boggi U, Kauffmann E, Napoli N, Barreto S, Besselink M, Fusai G, et al.
Ann Surg
. 2024 Feb;
280(1):56-65.
PMID: 38407228
Objective: The REDISCOVER consensus conference aimed at developing and validating guidelines on the perioperative care of patients with borderline-resectable (BR-) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC). Background: Coupled...
9.
Secanella L, Busquets J, Pelaez N, Sorribas M, Laquente B, Ruiz-Osuna S, et al.
Surg Oncol
. 2023 Dec;
52:102027.
PMID: 38113726
Introduction: Borderline Resectable Pancreatic Ductal Adenocarcinoma (BR-PDAC) benefits from neoadjuvant treatment (NAT) with the intent of surgical salvage in the absence of disease progression during chemotherapy (CT) or chemoradiotherapy (CRT)....
10.
Polette D, Busquets J, Secanella Medayo L, Sorribas Grifell M, Pelaez Serra N, Uribe C, et al.
Rev Esp Enferm Dig
. 2023 Nov;
116(4):209-215.
PMID: 38010101
Introduction: the diagnosis of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has increased significantly due to the widespread use of high-resolution imaging tests, which is why the most appropriate management...